RecallWatchUSA

Home / Recalls / Drugs

Novartis Pharmaceuticals Corp. recalls Lescol XL (fluvastatin sodium) Extended-Release Tablets, 80 mg per tablet, 7 tablets per bottle, Physician Sample-Not Fo

Recalled December 18, 2013 · FDA recall D-335-2014 · Novartis Pharmaceuticals

Hazard
Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due to contamination with Darocur 1173 a photocuring agent used in inks on shrink-wrap sleeves. · FDA Class II
Units
46,812 bottles
Sold at
Nationwide and Puerto Rico

Description

Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due to contamination with Darocur 1173 a photocuring agent used in inks on shrink-wrap sleeves.

Product
Lescol XL (fluvastatin sodium) Extended-Release Tablets, 80 mg per tablet, 7 tablets per bottle, Physician Sample-Not For Sale, Rx only. Manufactured by: Novartis Pharma Stein AG Stein, Switzerland. Distributed by: Novartis Pharmaceuticals Corp. East Hanover, New Jersey 07936, NDC # 0078-9354-07
Manufacturer(s)
Novartis Pharmaceuticals Corp.

Source: U.S. Food and Drug Administration. Official recall notice on fda.gov

Novartis Pharmaceuticals Corp. recalls Lescol XL (fluvastatin sodium) Extended-Release Tablets, 80 mg per tablet, 7 tablets per bottle, Physician Sample-Not Fo | RecallWatchUSA